Table IV.
Pathway 1 and description | Pathway 2 and description | Weight | Co-genes |
---|---|---|---|
hsa05323: | hsa04620: | 0.492651941 | CTSKa/CTSOa/FOS/IL8a/TLR2a |
Rheumatoid arthritis | Toll-like receptor signaling pathway | ||
hsa05142: | hsa04620: | 0.464920784 | IL8a/TLR2a/FOS |
Chagas disease (American trypanosomiasis) | Toll-like receptor signaling pathway | ||
hsa05146: | hsa04620: | 0.37284676 | IL8a/TLR2a/CD14a |
Amoebiasis | Toll-like receptor signaling pathway | ||
hsa04620 | hsa04060: | 0.351558647 | IL8a/CXCL10a |
Toll-like receptor signaling pathway | Cytokine-cytokine receptor interaction | ||
hsa04062: | hsa04060: | 0.33933744 | CCR1a/CXCL1a/CXCL3a/IL8a/ |
Chemokine signaling pathway | Cytokine-cytokine receptor interaction | CXCL10a/CCL28/CCL8a/CCL13a/CCL18a/CCL21/CXCL5a | |
hsa04380: | hsa04620: | 0.327230722 | CTSKa/FOS |
Osteoclast differentiation | Toll-like receptor signaling pathway | ||
hsa04974: | hsa04512: | 0.31737287 | COL5A1a/COL6A3a/COL11A1a/ |
Protein digestion and absorption | ECM-receptor interaction | COL5A3a | |
hsa04512: | hsa04510: | 0.307854633 | COL5A1a/COL6A3a/COL11A1a/ |
ECM-receptor interaction | Focal adhesion | COMPa/TNCa/IBSPa/ITGA2a/ITGA4a/ITGA5a/LAMB3a/COL5A3a/RELN/SPP1a/THBS2a/ | |
hsa04145: | hsa04620: | 0.305699295 | TLR2a/CD14a |
Phagosome | Toll-like receptor signaling pathway | ||
hsa05150: | hsa04610: | 0.272281647 | CFD/C1QAa/C1QBa/C1QCa/ |
Staphylococcus aureus infection | Complement and coagulation cascades | C3AR1a/C5AR1a |
Downregulated differentially expressed genes. ECM, extracellular matrix.